Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: A prospective study

Journal of Psychiatric Research

Volumn 35, Issue 2, 2001, Pages 83-94

  Zobel, Astrid W ^a   Nickel, Thomas ^a   Sonntag, Annette ^a   Uhr, Manfred ^a   Holsboer, Florian ^a   Ising, Marcus ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Cortisol response; Depression; DEX CRH test; Prediction; Relapse

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; REMISSION; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PATIENT DISCHARGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034993647     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00013-9     Document Type: Article

References (37)

1. Correlating and predicting psychiatric symptom ratings: Spearman's r versus Kendall's tau correlation
2. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralcorticoid receptor gene expression in rat brain. Therapeutic implications
3. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression
4. A rating scale for depression
5. The combined dexamethasone-/CRH-test: A refined laboratory test for psychiatric disorder
6. Age-associated changes of pituitary adrenocortical hormone regulation in humans: Importance of gender
7. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects
8. Neuroendocrinology of mood disorders
9. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
10. The corticosteroid receptor hypothesis of depression
11. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
12. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia
13. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression
14. Repeated administration of the combined dexamethasone - Human corticotropin releasing hormone stimulation test during treatment of depression
15. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - Neurobiological and psychometric assessment of course
16. Recurrence in affective disorder II - Effect of age and gender
17. Predictors of recurrence in affective disorder - Analyses accounting for individual heterogeneity
18. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice
19. A new depression scale designed to be sensitive to change
20. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function
21. cAMP-dependent phosphorylation system after short- and long-term administration of moclobemide
22. Psychological, autonomic, and neuroendocrine responses to acute stressors in the combined dexamethasone/CRH test: A study in healthy subjects
23. Physiology and pharmacology of corticotropin-releasing factor
24. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
25. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase - An inhibitor moclobemide
26. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness
27. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
28. Gender differences in patterns of HPA axis response to challenge: MacArthur studies of successful aging
29. Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone
30. Cortisol response to a combined dexamethasone - Human corticotropin-releasing hormone challenge in patients with depression
31. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone
32. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects
33. Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment
34. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
35. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression